Riskpilot← Back to searchSign inGet full accessSWE DEN 911 AB
ABActiveOrg 5592061849Götgatan 92Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20190 employees
Revenue 2025
SEK 28K
-32% vs 2024
EBITDA margin
-7.1%
-105% vs 2024
Equity ratio
83.3%
Financial strength
Net profit 2025
SEK -2K
-106% vs 2024
| Revenue | SEK 28K | -32% |
| EBITDA | SEK -2K | -105% |
| Net profit | SEK -2K | -106% |
| Total assets | SEK 48K | -25% |
| Equity | SEK 40K | -2% |
| Employees | 0 | — |
Legal name
SWE DEN 911 AB
Org number
5592061849
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
20 maj 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Uppgift om firmateckning saknas Styrelsen ska bestå av 3 styrelseledamöter och 0 styrelsesuppleanter. Registrerad behörig styrelse saknas. Därför saknas också uppgift om firmateckningsrätten.
Company purpose
Produktutveckling och försäljning av medicin-tekniska produkter inom områden sjukvård, sjukvårdsutbildning samt hjälpmedel. Produktion, import, export, produktutveckling och konsult- verksamhet inom allmänvård, försvar, sjukvård och utbildning.
Address
Götgatan 92
Email
ola64@mac.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 11 | 4 | 41 | 28 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −39 | −8 | −14 | 39 | −2 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −39 | −8 | −14 | 39 | −2 |
| Net financials | −1 | — | — | — | — |
| Profit before tax | −39 | −8 | −14 | 39 | −2 |
| Tax | −0 | −0 | −1 | −8 | −0 |
| Net profit | −39 | −8 | −15 | 31 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 35 | 27 | 14 | 64 | 48 |
| Equity | 32 | 25 | 10 | 41 | 40 |
| Long-term debt | 0 | 0 | 0 | 1 | 3 |
| Short-term debt | 2 | 2 | 4 | 21 | 5 |
| Total debt | 2 | 2 | 4 | 22 | 8 |
EBITDA margin
-7.1%
This company
15.8%
Market median
-145% vs market
20212025
Equity ratio
83.3%
This company
38.2%
Market median
+118% vs market
20212025
Return on equity
-5.0%
This company
18.4%
Market median
-127% vs market
20212025
Net profit margin
-7.1%
This company
8.1%
Market median
-188% vs market
20212025
Asset turnover
0.58×
This company
1.12×
Market median
-48% vs market
20212025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SWE DEN 911 AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rikard Fredrik Lundby | Board of Directors | 0 companies |
| Lukas Alexander Berg | Chairman | 0 companies |
| Ola Benjamin Öquist | Board of Directors | 0 companies |